Metal implants have the potential to trigger a type IV hypersensitivity reaction, where macrophage activation, induced by implant debris, leads to the release of interleukin (IL)-1b, the tumor necrosis factor, IL-6, and IL-8. The gene discussed is IL1B; the disease is type IV hypersensitivity disease.